As a result of our previous research focussed on benzimidazoles, herein we present design, synthesis, QSAR analysis and biological activity of novel N-substituted benzimidazole derived carboxamides. Carboxamides were designed to study the influence of the number of methoxy groups, the type of the substituent placed at the benzimidazole core on biological activity. Pronounced antioxidative activity displayed unsubstituted
28
(IC
50
≈ 3.78 mM, 538.81 mmolFe
2+
/mmolC) and dimethoxy substituted derivative
34
(IC
50
≈ 5.68 mM, 618.10 mmolFe
2+
/mmolC). Trimethoxy substituted
43
and unsubstituted compound
40
with isobutyl side chain at N atom showed strong activity against HCT116 (IC
50
≈ 0.6 µM, both) and H 460 cells (IC
50
≈ 2.5 µM; 0.4 µM), being less cytotoxic towards non-tumour cell. Antioxidative activity in cell generally confirmed relatively modest antioxidant capacity obtained in DPPH/FRAP assays of derivatives
34
and
40
. The 3D-QSAR models were generated to explore molecular properties that have the highest influence on antioxidative activity.